Catalyst Wire Dossier Catalyst Wire Dossier

Iclepertin

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Iclepertin, covering 2024-07-09 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study [Phase 3]

See pricing